Neuraxial blocks and anticoagulants (ASRA)
Why examiners ask this
Almost every regional stem contains an anticoagulant, and the examiner wants to see that you know the ASRA intervals, apply them to placement and catheter removal, and weigh the alternative when the interval has not been met. The current reference is the fifth edition of the ASRA guidelines, published in 2025.1 This is judgment more than memory: the trade-off between a catastrophic but rare spinal hematoma and the benefits of neuraxial analgesia, and the coordination needed with surgeons and medicine teams to time doses around a catheter.
The 60-second answer
I take a medication history that includes the drug, the dose, the time of the last dose and renal function, because the fifth edition classifies anticoagulants as low dose or high dose and ties several intervals to creatinine clearance.2 I apply the intervals for placement and for catheter removal, which carries the same risk as placement. Low-dose LMWH needs 12 hours and high-dose LMWH 24 hours.3 Warfarin is stopped 5 days ahead with a normalized INR. High-dose apixaban, rivaroxaban and edoxaban need 72 hours; low-dose apixaban needs 36 hours and low-dose rivaroxaban 24 hours.3 Clopidogrel needs 5–7 days, prasugrel 7–10 days and ticagrelor 5 days. NSAIDs and aspirin alone do not change timing.3 If the interval is not met, I choose a different technique rather than compromise. Whenever I place or remove a catheter in an anticoagulated patient, I order neurologic checks, because a hematoma decompressed within 8 hours has a much better outcome.4
Decision points and the "why"
- Removal is as dangerous as placement — I time catheter removal to the trough of the anticoagulant and delay the next dose: 4 hours after removal for low-dose LMWH, at least 6 hours for a low-dose DOAC, and at least 24 hours between needle placement or catheter removal and the first postoperative dose of a high-dose DOAC.3
- Combinations multiply risk — antiplatelet or oral anticoagulant drugs given with LMWH increase hematoma risk, and ASRA recommends against adding other hemostasis-altering drugs while a neuraxial catheter is in place with LMWH.3
- Renal function changes the clock — high-dose dabigatran needs 72 hours if creatinine clearance is at least 50 mL/min and 120 hours at 30–49 mL/min; low-dose dabigatran needs 48 hours; low-dose rivaroxaban extends to 30 hours below 30 mL/min. LMWH accumulates in renal failure, so I consider an anti-Xa level.3
- Subcutaneous heparin — 5000 units two or three times daily needs 4–6 hours or normal coagulation status; 7500–10,000 units twice daily (up to 20,000 units a day) needs 12 hours and a normal coagulation status; larger doses need 24 hours.3
- Intraoperative IV heparin is acceptable — I wait at least 1 hour after needle placement before giving it, and a heparin infusion is stopped 4–6 hours before a block with normal coagulation status; a bloody tap prompts discussion with the surgeon rather than mandatory cancellation.3
- Deep and plexus blocks follow neuraxial rules — deep plexus and deep peripheral blocks such as lumbar plexus are in non-compressible sites, so the same intervals apply; superficial blocks are judged on compressibility and vascularity.3
The complication they will inject
On postoperative day 2 after a total knee replacement, a patient with an epidural catheter removed six hours earlier, after enoxaparin was restarted, develops new bilateral leg weakness and back pain. I stop all anticoagulants, examine her, and tell the team this is an epidural hematoma until proven otherwise. I order an emergency MRI and call neurosurgery at the same time, rather than sequentially, because recovery is far more likely with laminectomy within 8 hours of the onset of deficits.4 I check coagulation studies and platelets and plan reversal with the hematology team. I disclose to the patient, document the timing of every dose, and review why the dose sequence violated the guideline: with twice-daily LMWH the catheter should have been removed before the first dose, with the dose delayed 4 hours after removal.3
Pitfalls that cost points
- Forgetting that catheter removal carries risk.
- Quoting one 72-hour interval for every DOAC without asking the dose and the renal function.
- Proceeding with a neuraxial block on a "borderline" interval when a peripheral block or IV technique would do.
- Attributing new weakness to the local anesthetic without stopping the infusion and checking for recovery within 2 hours.
- Ordering imaging and waiting for the result before calling the surgeon.
Rapid-why
Q: Why are NSAIDs alone acceptable? A: NSAIDs, including aspirin, do not add measurable risk of major bleeding, so ASRA sets no specific timing for blocks or catheter removal.3
Q: What INR is acceptable for catheter removal on warfarin? A: An INR below 1.5; if warfarin was started before surgery, I check the INR before placement when the first dose was more than 24 hours earlier or a second dose has been given, and I continue neurologic checks for 48 hours after removal.3
Q: Why the longer wait for high-dose LMWH? A: Anti-Xa activity persists longer after higher doses, especially in the elderly and renal impairment.
Q: Why can a patient on aspirin for a stent have a spinal? A: Aspirin alone does not prohibit neuraxial blocks; stopping it risks stent thrombosis.
Numbers to know
| Item | Value |
|---|---|
| LMWH low dose / high dose | 12 h / 24 h before placement3 |
| Next LMWH dose after removal | ≥4 h3 |
| Apixaban, rivaroxaban, edoxaban (high dose) | 72 h; first dose ≥24 h after placement or removal3 |
| Apixaban / rivaroxaban (low dose) | 36 h / 24 h; first dose ≥6 h after placement or removal3 |
| Dabigatran | High dose 72 h (CrCl ≥50) or 120 h (CrCl 30–49); low dose 48 h3 |
| Clopidogrel / prasugrel / ticagrelor | 5–7 d / 7–10 d / 5 d3 |
| Warfarin | Stop 5 d, normal INR; remove catheter at INR <1.53 |
| Hematoma decompression | Within 8 h of symptoms4 |
Links
- Epidural hematoma and abscess (coming), Regional anesthesia with pre-existing neuropathy (coming), Anticoagulation, thrombocytopenia and neuraxial blocks (coming), Recent MI, coronary stents and antiplatelet therapy, Thoracic epidural analgesia
- ASRA evidence-based guidelines on regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy (fifth edition, 2025); SOAP consensus on the anticoagulated obstetric patient
Sources
- 1.Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: ASRA Pain Medicine Evidence-Based Guidelines (fifth edition) · ASRA Pain Medicine, 2025 · asra.comASRA landing page for Kopp SL, Vandermeulen E, McBane RD, et al. Reg Anesth Pain Med 2025 (rapm-2024-105766); full text at rapm.bmj.com could not be fetched.
- 2.Block and Load: The ASRA's Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy - 5th edition · ESRA, 2025 · esraeurope.orgDescribes the move from prophylactic/therapeutic to low-dose/high-dose terminology and renal-function-based timelines.
- 3.ASRA Guidelines for Regional Anesthesia with Antithrombotic or Thrombolytic Therapy 5th Edition - Summary of Recommendations · Guideline Central / ASRA Pain Medicine, 2025 · guidelinecentral.comVerbatim recommendation list of the fifth edition, produced in participation with ASRA; source of every interval on this page.
- 4.Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: ASRA Evidence-Based Guidelines (Fourth Edition) · ASRA, 2018 · history.mayoclinic.orgCited only for the spinal hematoma outcome data (laminectomy within 8 hours of onset); intervals on this page follow the fifth edition.
Facts on this page were checked against these sources on Oct 14, 2026. Guidelines change; confirm doses against current institutional protocols.